Sabel MS - Search Results

1

Sarcopenia as a prognostic factor among patients with stage III melanoma.

Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S. Sabel MS, et al. Ann Surg Oncol. 2011 Dec;18(13):3579-85. doi: 10.1245/s10434-011-1976-9. Epub 2011 Aug 6. Ann Surg Oncol. 2011. PMID: 21822551

2

Evolution of sentinel lymph node biopsy for melanoma at a National Cancer Institute-designated cancer center.

Sabel MS, Gibbs JF, Cheney R, McKinley BP, Lee JS, Kraybill WG. Sabel MS, et al. Surgery. 2000 Oct;128(4):556-63. doi: 10.1067/msy.2000.108053. Surgery. 2000. PMID: 11015088

3

Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma.

Sabel MS, Zhang P, Barnwell JM, Winston JS, Hurd TC, Edge SB. Sabel MS, et al. J Surg Oncol. 2001 Aug;77(4):243-6. doi: 10.1002/jso.1103. J Surg Oncol. 2001. PMID: 11473372

4

Melanoma: adjuvant therapy and other treatment options.

Terando A, Sabel MS, Sondak VK. Terando A, et al. Among authors: sabel ms. Curr Treat Options Oncol. 2003 Jun;4(3):187-99. doi: 10.1007/s11864-003-0020-0. Curr Treat Options Oncol. 2003. PMID: 12718796 Review.

5

Sentinel node biopsy prior to neoadjuvant chemotherapy.

Sabel MS, Schott AF, Kleer CG, Merajver S, Cimmino VM, Diehl KM, Hayes DF, Chang AE, Pierce LJ. Sabel MS, et al. Am J Surg. 2003 Aug;186(2):102-5. doi: 10.1016/s0002-9610(03)00168-5. Am J Surg. 2003. PMID: 12885598

6

Is there a role for sentinel lymph node biopsy in the management of sarcoma?

Blazer DG 3rd, Sabel MS, Sondak VK. Blazer DG 3rd, et al. Among authors: sabel ms. Surg Oncol. 2003 Nov;12(3):201-6. doi: 10.1016/s0960-7404(03)00030-6. Surg Oncol. 2003. PMID: 12957624 Review.

7

Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients.

Degnim AC, Griffith KA, Sabel MS, Hayes DF, Cimmino VM, Diehl KM, Lucas PC, Snyder ML, Chang AE, Newman LA. Degnim AC, et al. Among authors: sabel ms. Cancer. 2003 Dec 1;98(11):2307-15. doi: 10.1002/cncr.11803. Cancer. 2003. PMID: 14635063 Free article.

8

Intratumoral IL-12 and TNF-alpha-loaded microspheres lead to regression of breast cancer and systemic antitumor immunity.

Sabel MS, Skitzki J, Stoolman L, Egilmez NK, Mathiowitz E, Bailey N, Chang WJ, Chang AE. Sabel MS, et al. Ann Surg Oncol. 2004 Feb;11(2):147-56. doi: 10.1245/aso.2004.03.022. Ann Surg Oncol. 2004. PMID: 14761917 Free article.

9

Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model.

Sondak VK, Taylor JM, Sabel MS, Wang Y, Lowe L, Grover AC, Chang AE, Yahanda AM, Moon J, Johnson TM. Sondak VK, et al. Among authors: sabel ms. Ann Surg Oncol. 2004 Mar;11(3):247-58. doi: 10.1245/aso.2004.03.044. Ann Surg Oncol. 2004. PMID: 14993019 Free article.

10

Efficacy of sentinel lymph node biopsy in male breast cancer.

Cimmino VM, Degnim AC, Sabel MS, Diehl KM, Newman LA, Chang AE. Cimmino VM, et al. Among authors: sabel ms. J Surg Oncol. 2004 May 1;86(2):74-7. doi: 10.1002/jso.20045. J Surg Oncol. 2004. PMID: 15112248 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page